CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Nirali N. Shah, Kniya DéDé et al.|Blood|2022Cited by 179
Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapyElizabeth M. Holland, Nirali N. Shah, Bonnie Yates et al.|Blood Advances|2021Cited by 67
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M. Holland, Nirali N. Shah, John C. Molina et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 59
Prospective Study Utilizing PET-CT and Next-Generation Sequencing to Evaluate for Peri-CAR T-Cell Non-CNS Extramedullary Disease in B-Acute Lymphoblastic LeukemiaBrynn B. Duncan, Nirali N. Shah, Alexander W. Rankin et al.|Transplantation and Cellular Therapy|2025Cited by 0